Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Kociolek, L. K.
Patel, S. J.
Shulman, S. T.
and
Gerding, D. N.
2015.
Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection.
Journal of the Pediatric Infectious Diseases Society,
Vol. 4,
Issue. 4,
p.
e139.
Kociolek, Larry K.
Patel, Sameer J.
Shulman, Stanford T.
and
Gerding, Dale N.
2015.
Molecular Epidemiology ofClostridium difficileInfections in Children: A Retrospective Cohort Study.
Infection Control & Hospital Epidemiology,
Vol. 36,
Issue. 4,
p.
445.
Stevens, Vanessa W.
Thurm, Cary
Schwab, Elyse M.
Kronman, Matthew P.
Gerber, Jeffrey S.
Shah, Samir S.
Newland, Jason G.
Courter, Joshua
Parker, Sarah
Brogan, Thomas V.
and
Hersh, Adam L.
2016.
Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study.
Infectious Diseases and Therapy,
Vol. 5,
Issue. 1,
p.
45.
Reveles, Kelly R.
Mortensen, Eric M.
Koeller, Jim M.
Lawson, Kenneth A.
Pugh, Mary Jo V.
Rumbellow, Sarah A.
Argamany, Jacqueline R.
and
Frei, Christopher R.
2018.
Derivation and Validation of aClostridium difficileInfection Recurrence Prediction Rule in a National Cohort of Veterans.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 38,
Issue. 3,
p.
349.
Loo, Vivian G
Davis, Ian
Embil, John
Evans, Gerald A
Hota, Susy
Lee, Christine
Lee, Todd C
Longtin, Yves
Louie, Thomas
Moayyedi, Paul
Poutanen, Susan
Simor, Andrew E
Steiner, Theodore
Thampi, Nisha
and
Valiquette, Louis
2018.
Association of Medical Microbiology and Infectious Disease Canada treatment practice guidelines for Clostridium difficile infection.
Official Journal of the Association of Medical Microbiology and Infectious Disease Canada,
Vol. 3,
Issue. 2,
p.
71.
Gould, Jane M.
and
Coffin, Susan E.
2018.
Principles and Practice of Pediatric Infectious Diseases.
p.
592.
Pichler, Karin
Bausenhardt, Benjamin
Huhulescu, Steliana
Lindtner, Claudia
Indra, Alexander
Allerberger, Franz
and
Berger, Angelika
2018.
Impact and Time Course of <b><i>Clostridium difficile</i></b> Colonization in Very Low Birth Weight Infants.
Neonatology,
Vol. 114,
Issue. 2,
p.
149.
Yin, Jianyi
Kociolek, Larry K
Same, Rebecca G
Hsu, Alice J
Amoah, Joe
and
Tamma, Pranita D
2019.
Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridioides difficile Infections.
Open Forum Infectious Diseases,
Vol. 6,
Issue. 12,
Sattler, Matthew M
and
Crews, Jonathan D
2021.
Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children.
Journal of the Pediatric Infectious Diseases Society,
Vol. 10,
Issue. Supplement_3,
p.
S27.
Mayer Arispe, Erick F.
and
Shane, Andi L.
2021.
Pediatric Transplant and Oncology Infectious Diseases.
p.
258.
Sandora, Thomas J
2023.
How Should We Determine the Role of Bezlotoxumab for Pediatric Clostridioides difficile Infection?.
Journal of the Pediatric Infectious Diseases Society,
Vol. 12,
Issue. 6,
p.
332.
Handy, Lori K.
Coffin, Susan E.
and
Gould, Jane M.
2023.
Principles and Practice of Pediatric Infectious Diseases.
p.
611.
Sandora, Thomas J.
Kociolek, Larry K.
Williams, David N.
Daugherty, Kaitlyn
Geer, Christine
Cuddemi, Christine
Chen, Xinhua
Xu, Hua
Savage, Timothy J.
Banz, Alice
Garey, Kevin W.
Gonzales-Luna, Anne J.
Kelly, Ciarán P.
and
Pollock, Nira R.
2023.
Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection.
Infection Control & Hospital Epidemiology,
Vol. 44,
Issue. 9,
p.
1403.